
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

AI-enforced ultra-large virtual screening is currently revolutionizing how we identify binders for challenging targets. In a landmark study, researchers targeted the CD28 immune receptor. This receptor is critical for T-cell activation but remains notoriously difficult to modulate with small molecules. Specifically, traditional screening methods often fail due to the receptor's shallow, solvent-exposed protein-protein interfaces. Consequently, the researchers utilized the PyRMD2Dock platform to overcome existing computational bottlenecks.
First, they docked a diverse subset of 2.4 million molecules. Next, they used these data to train 672 classification models. Subsequently, these models screened 46 million compounds from the Enamine REAL Diversity Space. This AI virtual screening CD28 approach identified 232 highly prioritized ligands. Ultimately, the experimental validation of 150 candidates yielded several potent binders.
Specifically, lead compounds 100 and 104 demonstrated submicromolar affinities of 343.8 nM and 407.1 nM. These molecules successfully disrupted the CD28-CD80 interaction. Moreover, the compounds reduced cytokine secretion in primary human tumor-PBMC models. In addition, this study validates PyRMD2Dock as a scalable protocol for mining massive chemical libraries. Therefore, this breakthrough offers a new path for discovering modulators for "undruggable" immune receptors.
CD28 is a critical costimulatory receptor on T-cells. It binds to CD80 or CD86 on antigen-presenting cells to provide the "second signal" required for full T-cell activation and survival.
Targeting CD28 is challenging because its binding interface is shallow and solvent-exposed. Unlike typical enzymes with deep pockets, these protein-protein interfaces lack the structural features usually required for high-affinity small-molecule binding.
AI improves screening by rapidly analyzing millions of compounds that would be computationally impossible to dock using traditional methods. It learns from a smaller subset of data to predict high-affinity binders across massive chemical libraries.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
Upadhyay S et al. AI-Enforced Ultra-Large Virtual Screening Discovers Potent CD28 Binders. J Chem Inf Model. 2026 Jun 11. doi: 10.1021/acs.jcim.6c00859. PMID: 42273851.
Amendola G, Cosconati S. PyRMD: AI-powered Virtual Screening. J Chem Inf Model. 2021;61(10):4905-4914. doi: 10.1021/acs.jcim.1c00653.
Roggia M et al. Streamlining Large Chemical Library Docking with Artificial Intelligence: the PyRMD2Dock Approach. J Chem Inf Model. 2024. doi: 10.1021/acs.jcim.4c00072.

A pioneering study using the PyRMD2Dock AI platform screened 46 million compounds to identify potent CD28 binders. These lead compounds effectively disrupt CD28-CD80 interactions and reduce cytokine levels, providing a scalable solution for targeting challenging immune receptors in oncology and rheumatology.
Today

A landmark study published in Cell Genomics reveals that overcrowding, poor sanitation, and socioeconomic inequality are primary drivers of global antimicrobial resistance. Reducing antibiotic consumption alone will not suffice, highlighting the urgent need for structural public health reforms by 2050.
Today

A new study reveals that hyperactivating the Hedgehog pathway with Smoothened Agonist (SAG) causes significant craniofacial development defects in mice. By disrupting cell proliferation and cell-cycle progression during a critical window, SAG exposure leads to cleft lip and other cranial abnormalities.
Today

A study of 221 patients reveals that IVUS guidance during intracoronary brachytherapy for in-stent restenosis significantly reduces target lesion revascularization (21% vs 37%) and major adverse cardiovascular events, ensuring better long-term procedural success and improved patient safety.
Today

Despite their expertise in ergonomics, physiotherapists face high rates of work-related musculoskeletal disorders. New research identifies low back pain and repetitive tasks as leading issues, with female practitioners showing significantly higher risk profiles compared to their male counterparts.
Today

A comprehensive pathological study reveals that medial and intimal calcification follow distinct, inverse distribution patterns in the lower extremities, with medial calcification significantly linked to chronic kidney disease.
Today